Cargando…
Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
BACKGROUND: Standard therapy for metastatic non small cell lung cancer (NSCLC) includes palliative systemic chemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intent stereotactic body radiation therapy (SBRT) have shown encouraging survival. We...
Autores principales: | Cheruvu, Praveena, Metcalfe, Su K, Metcalfe, Justin, Chen, Yuhchyau, Okunieff, Paul, Milano, Michael T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141527/ https://www.ncbi.nlm.nih.gov/pubmed/21718501 http://dx.doi.org/10.1186/1748-717X-6-80 |
Ejemplares similares
-
Outcomes of patients with unresected stage III and stage IV non-small cell lung cancer: A single institution experience
por: Tiwana, Manpreet Singh, et al.
Publicado: (2013) -
Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2021) -
The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012) -
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
por: Gao, Yinjie, et al.
Publicado: (2022) -
Lung microbiota features of stage III and IV non-small cell lung cancer patients without lung infection
por: Zhang, Miao, et al.
Publicado: (2022)